Literature DB >> 20660318

Saving lives with accurate HER2 testing.

Jeffrey S Ross.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660318     DOI: 10.1309/AJCP6VZ8YHMZNNED

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  4 in total

1.  Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

Authors:  Julian C Schink; Julia R Trosman; Christine B Weldon; Kalliopi P Siziopikou; Gregory J Tsongalis; Alfred W Rademaker; Jyoti D Patel; Al B Benson; Edith A Perez; William J Gradishar
Journal:  J Natl Cancer Inst       Date:  2014-09-12       Impact factor: 13.506

Review 2.  Drug repositioning for personalized medicine.

Authors:  Yvonne Y Li; Steven Jm Jones
Journal:  Genome Med       Date:  2012-03-30       Impact factor: 11.117

3.  High-density SNP arrays improve detection of HER2 amplification and polyploidy in breast tumors.

Authors:  Thomas V O Hansen; Jonas Vikesaa; Sine S Buhl; Henrik H Rossing; Vera Timmermans-Wielenga; Finn C Nielsen
Journal:  BMC Cancer       Date:  2015-02-06       Impact factor: 4.430

4.  The human epidermal growth factor receptor 2 screening tests for breast cancer suggested by the new updated recommendation of the american society of clinical oncology/college of american pathologists will involve a rise of the in-situ hybridization tests for the European laboratories of pathology.

Authors:  Christian Garbar; Aude-Marie Savoye; Corinne Mascaux; Eva Brabencova; Hervé Curé
Journal:  ISRN Oncol       Date:  2014-04-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.